Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Epinephrine by ARS Pharmaceuticals for Chronic Urticaria Or Hives: Likelihood of Approval
Epinephrine is under clinical development by ARS Pharmaceuticals and currently in Phase II for Chronic Urticaria Or Hives. According to...
Epinephrine by ARS Pharmaceuticals for Food Allergy: Likelihood of Approval
Epinephrine is under clinical development by ARS Pharmaceuticals and currently in Phase III for Food Allergy. According to GlobalData, Phase...
Epinephrine by Aquestive Therapeutics for Anaphylaxis: Likelihood of Approval
Epinephrine is under clinical development by Aquestive Therapeutics and currently in Phase I for Anaphylaxis. According to GlobalData, Phase I...
Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics's Epinephrine?
Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis. According to Globaldata,...
Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics's Epinephrine?
Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis. According to Globaldata,...